
Nicotinamide Riboside (NR) is a Vitamin B3 derivative and direct dietary precursor to nicotinamide adenine dinucleotide (NAD+) — a coenzyme essential to mitochondrial energy metabolism and cellular redox balance. However, unencapsulated NR presents well-documented handling challenges: pronounced hygroscopicity accelerates moisture-driven degradation, and rapid dissolution in aqueous environments complicates blend uniformity. Liposomal encapsulation addresses both. By enclosing NR (CAS 1341-23-7) within phospholipid bilayer vesicles — the same molecular architecture found in all cell membranes — this delivery system creates a moisture-protective micro-environment and modulates release behavior during manufacturing. The result is NR powder engineered for predictable performance across capsule, tablet, and beverage powder workflows. Available at 50% and 70% loading.
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in every living cell, cycling between oxidized and reduced states to shuttle electrons in enzymatic reactions — most critically within the mitochondrial electron transport chain. NAD+ is consumed continuously and must be replenished through endogenous biosynthesis.
NR enters this system via the NAD+ salvage pathway: NR is first phosphorylated by nicotinamide riboside kinases (NRK1/2) to NMN, then converted to NAD+ by NMN adenylyltransferase. This two-step biochemical route is one of the body’s endogenous mechanisms for maintaining cellular NAD+ availability.
The same nucleoside structure that enables NR’s cellular uptake also makes it inherently hygroscopic — absorbing atmospheric moisture during storage, blending, and capsule filling. In humid production environments, unencapsulated NR can exhibit visible caking, color shifts, and active-content drift within weeks of opening bulk containers.
Furthermore, NR’s aqueous solubility creates difficulties in wet-granulation and multi-phase beverage powder systems, where rapid, non-uniform dissolution can introduce content-variability issues batch to batch.
(1) Moisture Barrier. The phospholipid bilayer physically separates encapsulated NR from ambient humidity. While not an absolute seal, this lipid barrier slows moisture ingress — reducing hydrolytic degradation during manufacturing steps where controlled-humidity conditions are impractical.
(2) Controlled Aqueous Release. Liposomal vesicles swell gradually upon rehydration rather than bursting instantly. This modulated release supports more uniform blend distribution in wet-granulation and beverage premix operations.
(3) QC-Verified Quality. EE% ≥ 80% by dialysis/HPLC confirms genuine encapsulation — distinguishing this product from simple physical blends of NR with phospholipids. DLS particle sizing verifies consistent nano-scale vesicle dimensions (80–300 nm) across every batch.

NR’s moisture sensitivity is a practical problem — not a theoretical one. Unencapsulated NR shows visible caking and active-content drift within weeks. The phospholipid bilayer acts as a diffusion barrier, slowing water-vapor contact. For humid-climate manufacturers or extended production campaigns, this means more predictable batch performance and less waste.
50% offers balanced dosing for B3-complex, NAD+ precursor blends, and multivitamins. 70% maximizes NR per gram — enabling smaller capsules, fewer units per serving, and high-potency single-active products. Both grades share identical QC protocols and CoA documentation.
EE% ≥ 80% measured by dialysis/HPLC distinguishes true liposomal NR from simple dry blends of NR plus phospholipids. This analytical verification is documented on every CoA — not a one-off claim but a routine QC checkpoint.
Consistent 80–300 nm vesicles (PDI ≤ 0.35) indicate well-controlled emulsification and spray-drying. Larger or polydisperse populations suggest process variability that could affect rehydration and release behavior. DLS is run on every batch as a routine QC checkpoint.
Every batch tested to confirm 50% or 70% NR loading. Batch-specific CoA provided with each shipment.
Confirms stable liposome formation (80–300 nm) upon rehydration, verifying uniform nano-scale vesicle dimensions across production lots.
EE% ≥ 80% by dialysis/HPLC confirms genuine liposomal encapsulation rather than simple physical blending with phospholipids.
Full compliance: Pb ≤ 10 ppm, As/Cd ≤ 1 ppm, Hg ≤ 0.1 ppm; TPC / Yeast & Mold per USP; E. coli and Salmonella negative per 25g.
These statements describe established nutritional roles of Nicotinamide Riboside using structure/function language. They have not been evaluated by regulatory authorities. This product is not intended to diagnose, treat, cure, or prevent any disease.
NR is a dietary NAD+ precursor, feeding into the same coenzyme system that drives mitochondrial oxidative phosphorylation — the primary ATP-generating pathway. A foundational ingredient in energy-support and metabolic-wellness supplement lines for active-lifestyle consumers.
Within the Vitamin B3 family, NR’s pyridine-nucleoside structure sets it apart from nicotinic acid and nicotinamide. A differentiated, premium-positioned ingredient for B3-complex and NAD+ precursor supplement formulations targeting informed wellness consumers.
NAD+ and NADH constitute a fundamental redox couple in cellular biochemistry, participating in hundreds of oxidoreductase reactions. By contributing as a dietary NAD+ precursor, NR supports the body’s endogenous NAD+/NADH balance mechanisms.
As a recognized Vitamin B3-family member with a clear NAD+ precursor identity, NR fits naturally into broad-spectrum multivitamins, B-complex blends, and general-wellness supplement formulations. Science-grounded narrative supports consumer-facing product communication.
50% grade integrates into multi-component B-complex and NAD+ precursor blend capsules. 200–450 mg fill weights; compatible with high-speed capsule filling lines.
70% grade enables 100–300 mg active NR per compact capsule — optimizing capsule dimensions and packaging-to-active ratios for single-active NR supplement SKUs.
Both grades compatible with stick packs, sachets, and powdered drink mixes. The liposomal carrier supports more uniform dispersion and rehydration in multi-phase beverage powder systems.
NR as a differentiated B3-family ingredient in comprehensive multivitamin and wellness-stack formulations. Compatible with capsule, tablet, and powder formats. Non-GMO phospholipid sourcing supports clean-label positioning.